Another Name艾德拉尼,Zydelig,LuciDela
IndicationsA kinase inhibitor used in combination with rituximab for the treatment of relapsed chronic lymphocytic leukemia.
Reg No.03 L 1312/25
Inspection No.575-25
WhatsApp: